血小板和血栓抗脂综合征
Ibrahim Tohidi-Esfahani1,2, Prabal Mittal3,4, David Isenberg5
1Haematology Department, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Journal of clinical medicine
|February 10, 2024
概括
抗脂抗体综合征 (APS) 涉及由于抗脂抗体 (aPL) 的血栓形成. 血小板高反应性是关键,但抗血小板疗法是有限的,需要更好的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 抗脂抗体综合征 (APS) 是一种自身免疫性疾病,导致复发性血栓形成.
- 标准护理 (VKA) 往往不足,导致严重的发病率.
- 血小板过敏反应是APS病理生理学的核心机制.
研究的目的:
- 审查APS中血小板激活的证据.
- 探索血小板在与APS相关的血栓形成中的作用.
- 评估当前抗血小板治疗的有效性和未来的方向.
主要方法:
- 临床结果研究的文献综述.
- 对APS中血小板激活的病理生理机制的分析.
- 检查关于抗血小板治疗的现有数据.
主要成果:
- 血小板激活和聚合是APS血栓形成途径的常见终点.
- 过度的血小板反应性在APS中得到了明确的证明.
- 目前的抗血小板疗法作用有限,主要是针对特定病例的低剂量阿司匹林.
结论:
- 血小板过敏反应是APS相关血栓形成的关键因素.
- 准血小板通路可能会提供新的治疗途径.
- 需要进一步的研究来优化针对APS的抗血小板策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
524
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
524
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Disorders of Hemostasis
911
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
911
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K


